26 November 2019: Stem cells are undifferentiated cells which can multiply into several other types of cells and also into same type of stem cells. There are two forms of stem cells- embryonic stem cells and adult stem cells. Embryonic stem cells, as the name suggests, are isolated during the early embryonic phase whereas adult stem cells are isolated from fully grown individuals. Stem cells are being studied by researchers all over the world for their unique regenerative characteristics and applications in medicine.
Cell Acquisition Technology Segment to Contribute Significant Demand to the Market
The major technology variants of the stem cell market include cell production (in-vitro fertilization, isolation, therapeutic cloning, and cell culture), cell acquisition (apheresis, bone marrow harvest, and umbilical blood cord), expansion and sub-culture, and cryopreservation.
The cell acquisition sector accounted for the largest share in the stem cell industry and is anticipated to expand at the fastest CAGR in the forthcoming period. It is driven by rising consciousness regarding the importance and applicability of stem cells. Usually, bone marrow technology is used for cell acquisition on account of comparatively quicker production of new cells from bone marrow. Furthermore, cells that derive from bone marrow are more concentrated as compared to other origins.
The cell production segment accounted for a substantial share on account of increasing need from several clinical applications and ongoing technological advancements. On the basis of steps, the segment is classified into in-vitro fertilization, therapeutic cloning, isolation, and cell culture. The increasing number of organ replacement methods along with the demand for therapeutic has stimulated the sector development.
Market Insights:
Establishments are selecting multidisciplinary business expansion and multi-sector associations to ensure a constant supply of high quality differentiated and pluripotent cells. This is set to strengthen the competition, driving the need to launch innovative products continuously.
Becton Dickinson Biosciences is a world leader in bringing innovative research and diagnostic tools to laboratory professionals, life science researchers, clinical researchers, clinicians, and laboratory researchers. They are involved in drug discovery and development, basic research, disease management, and biopharmaceutical production.
Leading players operating in the stem cell market include STEMCELL Technologies Inc.; Celgene Corporation; Osiris Therapeutics Inc.; Advanced Cell Technology Inc.; BIOTIME, INC.; Cytori Therapeutics; Human Longevity Inc.; Cynata; Promethera Biosciences; and Mesoblast.
No comments:
Post a Comment